Search Within

CTCR Scholars

Formats
  1. Meeting Abstract (873)
  2. Journal Article (564)
  3. Review (72)
  4. Research Letter (38)
  5. Editorial (29)
  6. Correspondence (24)
  7. Miscellaneous (17)
  8. Book Section (11)
  9. Guidelines (7)
  10. Conference Paper (4)
Groups
  1. Department of Medicine (1415)
  2. Hematologic Malignancies, Division of (1082)
  3. MSK Grad Students (1018)
  4. Center for Hematologic Malignancies (985)
  5. Master of Science in Clinical and Translational Cancer Research (983)
  6. Survivorship Research (917)

More Groups

People
  1. Sergio Giralt (553)
  2. Miguel-Angel Perales (411)
  3. Michael Scordo (385)
  4. Gunjan Shah (341)
  5. Sean Devlin (333)
  6. Parastoo Dahi (305)

More People

Years
  1. 2025 (98)
  2. 2024 (251)
  3. 2023 (261)
  4. 2022 (230)
  5. 2021 (166)
  6. 2020 (211)

More Years

Publications
  1. Blood (318)
  2. Biology of Blood and Marrow Transplantation (187)
  3. Journal of Clinical Oncology (144)
  4. Annals of Surgical Oncology (83)
  5. Bone Marrow Transplantation (65)
  6. Transplantation and Cellular Therapy (56)

More Publications

Publishers
  1. Elsevier Inc. (390)
  2. American Society of Hematology (372)
  3. American Society of Clinical Oncology (158)
  4. Nature Publishing Group (134)
  5. Springer (102)
  6. American Association for Cancer Research (65)

More Publishers

Results (1639)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A pilot plant based dietary intervention in MGUS and SMM patients with elevated BMI is feasible and associated with improvements in metabolic and microbiome biomarkers of progression
    Meeting Abstract

    Shah, U. A.; Derkach, A.; Castro, F.; Anuraj, A.; Blaslov, J.; Tran, L.; Adintori, P. A.; Burge, M.; Funkhouser, S.; Hosszu, K.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • Tracking immune reconstitution in the bone marrow following allogeneic hematopoietic transplantation in humans reveals early dominance of innate lymphoid populations
    Meeting Abstract

    DeWolf, S.; Kuttiyara, J.; Vinci, P.; Slingerland, J.; Marcello, L. T.; Giardina, P. A.; Donohoe, W.; Lin, R. J.; Papadopoulos, E. B.; Gyurkocza, B.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • Outcomes and management of SARS-CoV2 omicron variant in recipients of hematopoietic cell transplantation (HCT) and CAR-T therapy
    Meeting Abstract

    Infante, M. S.; DeWolf, S.; Tamari, R.; Dahi, P. B.; Lee, Y. J.; Politikos, I.; Barker, J. N.; Babady, N. E.; Ramanathan, L.; Seo, S.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • Predictors and implications of renal injury in large cell lymphoma patients receiving CD19 CAR T cell therapy
    Meeting Abstract

    Boardman, A. P.; Gutgarts, V.; Flynn, J. R.; Devlin, S. M.; Tomas, A. A.; Fein, J. A.; Slingerland, J.; Parascondola, A.; Lin, R. J.; Scordo, M.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • A phase 2 trial of colesevelam for lenalidomide-associated diarrhea
    Meeting Abstract

    Hultcrantz, M.; Hassoun, H.; Korde, N.; Mailankody, S.; Shekarkhand, T.; Burge, M.; Maclachlan, K. H.; Patel, D.; Shah, U. A.; Chung, D. J.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • Outcomes for patients with relapsed and refractory peripheral T-cell lymphoma in the 21st century by relapse status, salvage therapy, and receipt of allogeneic transplant
    Meeting Abstract

    Stuver, R.; Epstein-Peterson, Z. D.; Johnson, W. T.; Khan, N.; Sauter, C. S.; Scordo, M.; Shah, G. L.; Moskowitz, A. J.; Horwitz, S. M.
    Blood (2022)

    Fulltext@MSK | Save
  • Maintenance Therapy Cessation for Sustained MRD Negative Multiple Myeloma Patients
    Meeting Abstract

    Korde, N.; Diamond, B.; Burge, M.; Hassoun, H.; Landau, H.; Hultcrantz, M.; Mailankody, S.; Maclachlan, K. H.; Shah, U. A.; Derkach, A.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • Prospective analysis to determine barriers to allogeneic hematopoietic cell transplantation in patients with newly diagnosed and relapsed acute leukemia
    Meeting Abstract

    Nath, K.; Lee, J.; Elko, T. A.; Levy, L.; Preston, E.; Devlin, S. M.; Ponce, D. M.; Lin, R. J.; Shaffer, B. C.; Cho, C.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • Carfilzomib, lenalidomide and dexamethasone (KRd) vs bortezomib, lenalidomide, and dexamethasone (VRd) as induction therapy in newly diagnosed high-risk multiple myeloma
    Meeting Abstract

    Tan, C.; Nemirovsky, D.; Derkach, A.; Hultcrantz, M.; Hassoun, H.; Mailankody, S.; Shah, U. A.; Patel, D.; Maclachlan, K. H.; Lahoud, O. B.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • Population pharmacokinetic model identifies an optimal fludarabine exposure for improved outcomes after CD19-directed CAR T cell therapy for aggressive B-NHL: Analysis from the Cell Therapy Consortium
    Meeting Abstract

    Scordo, M.; Flynn, J. R.; Devlin, S. M.; Gonen, M.; Parascondola, A.; Tomas, A. A.; Shouval, R.; Brower, J.; Porter, D. L.; Schuster, S. J.; more...
    Blood (2022)

    Fulltext@MSK | Save